Renalytix Ai Stock Investor Sentiment

RNLX Stock  USD 0.13  0  1.62%   
Slightly above 51% of Renalytix's investor base is interested to short. The analysis of the overall investor sentiment regarding Renalytix AI suggests that many traders are impartial. Renalytix's investing sentiment can be driven by a variety of factors including economic data, Renalytix's earnings reports, geopolitical events, and overall market trends.
  

Renalytix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Renalytix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at news.google.com         
Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Renalytix plc Announces Director Resignation and Shareholder Voting Results
news
over three weeks ago at news.google.com         
Renalytix AI Sees Shift in Voting Rights Control - TipRanks
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subj...
Macroaxis News
over a month ago at news.google.com         
Commencement of trading on OTCQB in the United States - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
Renalytix AI Clinches 11.8M in Optimistic Fundraise - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Renalytix AI Eyes Growth with 10M Fundraise and Restructuring - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix Reveals Total Share Capital and Voting Rights - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix AI Secures Nasdaq Listing Extension - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix Welcomes New Joint Corporate Broker - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix AI Ends Sale Process, Refocuses Strategy - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix Announces Share Capital and KidneyIntelX Test - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix AI shares hold buy rating from HC Wainwright By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Renalytix AI Reduces Debt with New Share Issue - TipRanks
Google News at Macroaxis
over three months ago at benzinga.com         
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
benzinga news
Far too much social signal, news, headlines, and media speculation about Renalytix that are available to investors today. That information is available publicly through Renalytix media outlets and privately through word of mouth or via Renalytix internal channels. However, regardless of the origin, that massive amount of Renalytix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Renalytix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Renalytix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Renalytix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Renalytix alpha.

Renalytix Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Renalytix AI Eyes Growth with 10M Fundraise and Restructuring - TipRanks
09/30/2024
2
Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3
11/01/2024
3
Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com
11/20/2024

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.